Drug intelligence / Profile preview

Codimex CT

Development stage
Unknown
Lead developer
Regal Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Codimex CT is a generic antihistamine product developed and manufactured by Regal Pharmaceuticals in Kenya. Its active ingredient is cetirizine dihydrochloride (10mg), a long-acting, non-sedating piperazine derivative that acts as a selective histamine H1 receptor antagonist. The drug is formulated as white, oval-shaped film-coated tablets for oral administration. It is primarily used for the symptomatic relief of allergic conditions, including allergic rhinitis (hay fever) and chronic urticaria. Additionally, it is indicated for managing symptoms associated with colds and flus, such as sneezing, runny nose, watery eyes, and blocked nose, as well as various allergic skin conditions. Cetirizine also exhibits some mast-cell stabilizing activity, contributing to its anti-allergic profile.

Brand names
Codimex CT
Other names
Codimex-CT
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Codimex CT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codimex CT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call